p53 gene status as a predictor of tumor response to induction chemotherapy of patients with locoregionally advanced squamous cell carcinomas of the head and neck
ContributorsTemam, S.; Flahault, Antoine; Perie, S.; Monceaux, G.; Coulet, F.; Callard, P.; Bernaudin, J. F.; St Guily, J. L.; Fouret, P.
Published inJournal of clinical oncology, vol. 18, no. 2, p. 385-394
Publication date2000
Keywords
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols/therapeutic use
- Carcinoma, Squamous Cell/drug therapy/genetics/pathology
- Cisplatin/administration & dosage
- Female
- Fluorouracil/administration & dosage
- Gene Expression Regulation, Neoplastic
- Genes, p53/genetics
- Head and Neck Neoplasms/drug therapy/genetics/pathology
- Humans
- Male
- Middle Aged
- Point Mutation
- Polymerase Chain Reaction
- Predictive Value of Tests
- Risk Assessment
- Treatment Outcome
- Tumor Markers, Biological/analysis
Affiliation entities Not a UNIGE publication
Citation (ISO format)
TEMAM, S. et al. p53 gene status as a predictor of tumor response to induction chemotherapy of patients with locoregionally advanced squamous cell carcinomas of the head and neck. In: Journal of clinical oncology, 2000, vol. 18, n° 2, p. 385–394. doi: 10.1200/JCO.2000.18.2.385
Main files (1)
Article (Published version)
Identifiers
- PID : unige:47150
- DOI : 10.1200/JCO.2000.18.2.385
- PMID : 10637254
Journal ISSN0732-183X
